Curtis SP - Search Results

1

Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.

Ruff CT, Morrow DA, Jarolim P, Ren F, Contant CF, Kaur A, Curtis SP, Laine L, Cannon CP, Brune K. Ruff CT, et al. Among authors: curtis sp. J Rheumatol. 2011 Jun;38(6):1071-8. doi: 10.3899/jrheum.100880. Epub 2011 Apr 1. J Rheumatol. 2011. PMID: 21459935

2

Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.

Cannon CP, Curtis SP, Bolognese JA, Laine L; MEDAL Steering Committee. Cannon CP, et al. Among authors: curtis sp. Am Heart J. 2006 Aug;152(2):237-45. doi: 10.1016/j.ahj.2006.05.024. Am Heart J. 2006. PMID: 16875903

3

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin AS, Bombardier C, Weinblatt ME, van der Heijde D, Erdmann E, Laine L; MEDAL Steering Committee. Cannon CP, et al. Among authors: curtis sp. Lancet. 2006 Nov 18;368(9549):1771-81. doi: 10.1016/S0140-6736(06)69666-9. Lancet. 2006. PMID: 17113426

4

Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study).

Combe B, Swergold G, McLay J, McCarthy T, Zerbini C, Emery P, Connors L, Kaur A, Curtis S, Laine L, Cannon CP. Combe B, et al. Rheumatology (Oxford). 2009 Apr;48(4):425-32. doi: 10.1093/rheumatology/kep005. Epub 2009 Feb 17. Rheumatology (Oxford). 2009. PMID: 19223284 Clinical Trial.

5

Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.

Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP. Laine L, et al. Among authors: curtis sp. Aliment Pharmacol Ther. 2010 Nov;32(10):1240-8. doi: 10.1111/j.1365-2036.2010.04465.x. Epub 2010 Sep 23. Aliment Pharmacol Ther. 2010. PMID: 20955443 Free article. Clinical Trial.

6

Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs.

Krum H, Swergold G, Gammaitoni A, Peloso PM, Smugar SS, Curtis SP, Brater DC, Wang H, Kaur A, Laine L, Weir MR, Cannon CP. Krum H, et al. Among authors: curtis sp. Cardiovasc Ther. 2012 Dec;30(6):342-50. doi: 10.1111/j.1755-5922.2011.00283.x. Epub 2011 May 25. Cardiovasc Ther. 2012. PMID: 21884017 Free article. Clinical Trial.

7

Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines.

Laine L, Connors L, Griffin MR, Curtis SP, Kaur A, Cannon CP. Laine L, et al. Among authors: curtis sp. Aliment Pharmacol Ther. 2009 Oct;30(7):767-74. doi: 10.1111/j.1365-2036.2009.04090.x. Epub 2009 Jul 7. Aliment Pharmacol Ther. 2009. PMID: 19594486 Free article. Clinical Trial.

8

Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP; MEDAL Steering Committee. Laine L, et al. Among authors: curtis sp. Lancet. 2007 Feb 10;369(9560):465-73. doi: 10.1016/S0140-6736(07)60234-7. Lancet. 2007. PMID: 17292766

9

Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.

Baraf HS, Fuentealba C, Greenwald M, Brzezicki J, O'Brien K, Soffer B, Polis A, Bird S, Kaur A, Curtis SP; EDGE Study Group. Baraf HS, et al. Among authors: curtis sp. J Rheumatol. 2007 Feb;34(2):408-20. J Rheumatol. 2007. PMID: 17304660 Clinical Trial.

10

Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.

Laine L, Curtis SP, Langman M, Jensen DM, Cryer B, Kaur A, Cannon CP. Laine L, et al. Among authors: curtis sp. Gastroenterology. 2008 Nov;135(5):1517-25. doi: 10.1053/j.gastro.2008.07.067. Epub 2008 Aug 3. Gastroenterology. 2008. PMID: 18823986 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page